In vitro evaluation of the relative thrombolytic efficiency of forced intrathrombic injections: saline versus urokinase.
OBJECTIVE
To compare the rates of thrombolysis produced by forced intrathrombic injections of saline versus urokinase, as well as automated versus manual injections of urokinase, with use of an in vitro model of a vascular occlusion.


METHODS
The rates of thrombolysis produced by forced intrathrombic injections of saline and urokinase were compared in an in vitro radiometric model utilizing I-125-labeled thrombus. Similar experiments were performed to compare manual and automated injections of urokinase. The dissolution of the thrombus was quantitatively monitored with use of a scintillation detector. Averaged time activity data for each type of experiment were fit to exponential functions and half times of lysis calculated. The differences in the half times for the experiments being compared were evaluated for significance with use of the Student t test.


RESULTS
The half times of lysis produced by forced intrathrombic injections of urokinase were substantially and significantly shorter than those produced by forced saline injections. The half time of lysis produced by automated injections was not significantly different than that produced by manual injections.


CONCLUSIONS
Forced intrathrombic injections of urokinase produce faster and substantially more thrombolysis when compared with similarly administered saline. Also, for forced intrathrombic injections of lytic agents, an automated injector is an equivalent alternative to manual injections.
Khilnani
N M
NM
Department of Radiology, The New York Hospital-Cornell Medical Center, NY 10021, USA.
Winchester
P A
PA
Zanzonico
P
P
Trost
D W
DW
Binkert
B
B
Sos
T A
TA
D002404:Catheterization; D006801:Humans; D007267:Injections / Q000295:instrumentation / Q000379:methods; D010960:Plasminogen Activators / Q000008:administration & dosage*; D012965:Sodium Chloride / Q000008:administration & dosage; D015912:Thrombolytic Therapy / Q000295:instrumentation / Q000379:methods*; D013927:Thrombosis / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage*
D012965:Sodium Chloride; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator